TY  - JOUR
AU  - Dómine, M
AU  - Moran, T
AU  - Isla, D
AU  - Martí, J L
AU  - Sullivan, I
AU  - Provencio, M
AU  - Olmedo, M E
AU  - Ponce, S
AU  - Blasco, A
AU  - Cobo, M
PY  - 2020
DO  - 10.1007/s12094-020-02295-w
UR  - http://hdl.handle.net/10668/15080
T2  - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
AB  - Small-cell lung cancer (SCLC) accounts for 15% of lung cancers. Only one-third of patients are diagnosed at limited stage. The median survival remains to be around 15-20 months without significative changes in the strategies of treatment for many...
LA  - en
KW  - Chemotherapy
KW  - Immunotherapy
KW  - Radiotherapy
KW  - SCLC
KW  - Clinical Trials as Topic
KW  - Humans
KW  - Lung Neoplasms
KW  - Medical Oncology
KW  - Practice Guidelines as Topic
KW  - Small Cell Lung Carcinoma
KW  - Societies, Medical
TI  - SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
TY  - research article
VL  - 22
ER  -